_MEMBER_GenesID,_LogP_GenesID,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-2.5,GO:1903019,negative regulation of glycoprotein metabolic process,M1,1,0
1,-3.2,GO:0021535,cell migration in hindbrain,M1,1,0
1,-2.3,GO:0045671,negative regulation of osteoclast differentiation,M1,1,0
1,-4.3,GO:0090287,regulation of cellular response to growth factor stimulus,M1,1,0
1,-4.1,GO:0002708,positive regulation of lymphocyte mediated immunity,M1,1,0
1,-2.2,GO:0090183,regulation of kidney development,M1,1,0
1,-2.2,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M1,1,0
1,-3.2,GO:0002821,positive regulation of adaptive immune response,M1,1,0
1,-2,GO:0051960,regulation of nervous system development,M1,1,0
1,-2.2,GO:0072329,monocarboxylic acid catabolic process,M1,1,0
1,-2.1,GO:0098773,skin epidermis development,M1,1,0
1,-5.6,GO:1903034,regulation of response to wounding,M1,1,0
1,-3,GO:0003094,glomerular filtration,M1,1,0
1,-3.3,GO:0046642,negative regulation of alpha-beta T cell proliferation,M1,1,0
1,-2.6,GO:0008015,blood circulation,M1,1,0
1,-3.8,GO:0005342,organic acid transmembrane transporter activity,M1,1,0
1,-3.5,GO:0031901,early endosome membrane,M1,1,0
1,-2.8,GO:0044706,multi-multicellular organism process,M1,1,0
1,-3.8,GO:0006970,response to osmotic stress,M1,1,0
1,-4.4,GO:1900180,regulation of protein localization to nucleus,M1,1,0
1,-2.6,GO:0007369,gastrulation,M1,1,0
1,-2.5,GO:0007405,neuroblast proliferation,M1,1,0
1,-4.4,GO:1902107,positive regulation of leukocyte differentiation,M1,1,0
1,-3.4,GO:0021781,glial cell fate commitment,M1,1,0
1,-5.2,GO:0048863,stem cell differentiation,M1,1,0
1,-3.4,GO:0002573,myeloid leukocyte differentiation,M1,1,0
1,-2.7,GO:0030522,intracellular receptor signaling pathway,M1,1,0
1,-2.4,GO:0002889,regulation of immunoglobulin mediated immune response,M1,1,0
1,-3.6,GO:0060627,regulation of vesicle-mediated transport,M1,1,0
1,-4.2,GO:2000351,regulation of endothelial cell apoptotic process,M1,1,0
1,-3.4,GO:0001954,positive regulation of cell-matrix adhesion,M1,1,0
1,-4.1,GO:0061042,vascular wound healing,M1,1,0
1,-7.6,GO:0051251,positive regulation of lymphocyte activation,M1,1,0
1,-16,GO:0098552,side of membrane,M1,1,0
1,-3.9,GO:0002070,epithelial cell maturation,M1,1,0
1,-3.7,GO:0001894,tissue homeostasis,M1,1,0
1,-2.8,GO:0033630,positive regulation of cell adhesion mediated by integrin,M1,1,0
1,-2.1,GO:0046822,regulation of nucleocytoplasmic transport,M1,1,0
1,-4.7,GO:0048729,tissue morphogenesis,M1,1,0
1,-2.3,GO:0051851,host-mediated perturbation of symbiont process,M1,1,0
1,-2.7,GO:0003197,endocardial cushion development,M1,1,0
1,-2.5,GO:0090497,mesenchymal cell migration,M1,1,0
1,-4.5,GO:0043408,regulation of MAPK cascade,M1,1,0
1,-4,GO:0032787,monocarboxylic acid metabolic process,M1,1,0
1,-2,GO:0002891,positive regulation of immunoglobulin mediated immune response,M1,1,0
1,-12,GO:0030097,hemopoiesis,M1,1,0
1,-12,GO:0043235,receptor complex,M1,1,0
1,-2.3,GO:0050840,extracellular matrix binding,M1,1,0
1,-2.2,GO:2000379,positive regulation of reactive oxygen species metabolic process,M1,1,0
1,-2.2,GO:0030032,lamellipodium assembly,M1,1,0
1,-3,GO:0015718,monocarboxylic acid transport,M1,1,0
1,-6.2,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,M1,1,0
1,-3.3,GO:0030136,clathrin-coated vesicle,M1,1,0
1,-3.2,GO:0072330,monocarboxylic acid biosynthetic process,M1,1,0
1,-12,GO:0001525,angiogenesis,M1,1,0
1,-2.3,GO:0014013,regulation of gliogenesis,M1,1,0
1,-5.2,GO:0032870,cellular response to hormone stimulus,M1,1,0
1,-2.9,GO:0045089,positive regulation of innate immune response,M1,1,0
1,-3.6,GO:0050820,positive regulation of coagulation,M1,1,0
1,-2.3,GO:0060325,face morphogenesis,M1,1,0
1,-2.8,GO:0048880,sensory system development,M1,1,0
1,-4.6,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,M1,1,0
1,-2.8,GO:0016301,kinase activity,M1,1,0
1,-2.4,GO:1905954,positive regulation of lipid localization,M1,1,0
1,-5.3,GO:0032946,positive regulation of mononuclear cell proliferation,M1,1,0
1,-2.9,GO:0055082,intracellular chemical homeostasis,M1,1,0
1,-2.3,GO:0019956,chemokine binding,M1,1,0
1,-2.8,GO:2000027,regulation of animal organ morphogenesis,M1,1,0
1,-2,GO:0001818,negative regulation of cytokine production,M1,1,0
1,-2,GO:0017111,ribonucleoside triphosphate phosphatase activity,M1,1,0
1,-2.3,GO:0001961,positive regulation of cytokine-mediated signaling pathway,M1,1,0
1,-2.8,GO:0032656,regulation of interleukin-13 production,M1,1,0
1,-2.9,GO:0045661,regulation of myoblast differentiation,M1,1,0
1,-2.1,GO:0019218,regulation of steroid metabolic process,M1,1,0
1,-3.5,GO:0046643,regulation of gamma-delta T cell activation,M1,1,0
1,-3.5,GO:0042310,vasoconstriction,M1,1,0
1,-6.5,GO:0008283,cell population proliferation,M1,1,0
1,-4.8,GO:0050729,positive regulation of inflammatory response,M1,1,0
1,-2.4,GO:0033688,regulation of osteoblast proliferation,M1,1,0
1,-4.1,GO:0042471,ear morphogenesis,M1,1,0
1,-2.1,GO:0055094,response to lipoprotein particle,M1,1,0
1,-2.7,GO:0034103,regulation of tissue remodeling,M1,1,0
1,-4.4,GO:0043410,positive regulation of MAPK cascade,M1,1,0
1,-3.1,GO:0070206,protein trimerization,M1,1,0
1,-4.3,GO:0046624,sphingolipid transporter activity,M1,1,0
1,-3.3,GO:0010766,negative regulation of sodium ion transport,M1,1,0
1,-2.9,GO:0002768,immune response-regulating cell surface receptor signaling pathway,M1,1,0
1,-2,GO:0001990,regulation of systemic arterial blood pressure by hormone,M1,1,0
1,-3,GO:0032689,negative regulation of type II interferon production,M1,1,0
1,-4,GO:0045824,negative regulation of innate immune response,M1,1,0
1,-2.3,GO:0009755,hormone-mediated signaling pathway,M1,1,0
1,-2.4,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",M1,1,0
1,-4.9,GO:0030098,lymphocyte differentiation,M1,1,0
1,-3.9,GO:0005976,polysaccharide metabolic process,M1,1,0
1,-2.5,GO:1903018,regulation of glycoprotein metabolic process,M1,1,0
1,-2,GO:0040007,growth,M1,1,0
1,-3.1,GO:0042169,SH2 domain binding,M1,1,0
1,-4.9,GO:0071559,response to transforming growth factor beta,M1,1,0
1,-8,GO:0140375,immune receptor activity,M1,1,0
1,-7.9,GO:0032944,regulation of mononuclear cell proliferation,M1,1,0
1,-2.6,GO:0016310,phosphorylation,M1,1,0
1,-2.1,GO:0035633,maintenance of blood-brain barrier,M1,1,0
1,-2.1,GO:1905360,GTPase complex,M1,1,0
1,-3.1,GO:0019897,extrinsic component of plasma membrane,M1,1,0
1,-2.4,GO:0044298,cell body membrane,M1,1,0
1,-6.2,GO:0002819,regulation of adaptive immune response,M1,1,0
1,-4.4,GO:0005911,cell-cell junction,M1,1,0
1,-3.6,GO:0044403,biological process involved in symbiotic interaction,M1,1,0
1,-4,GO:0070664,negative regulation of leukocyte proliferation,M1,1,0
1,-2.7,GO:0030055,cell-substrate junction,M1,1,0
1,-3.5,GO:0042910,xenobiotic transmembrane transporter activity,M1,1,0
1,-8,GO:0048871,multicellular organismal-level homeostasis,M1,1,0
1,-3,GO:0090066,regulation of anatomical structure size,M1,1,0
1,-2.2,GO:0051385,response to mineralocorticoid,M1,1,0
1,-3.2,GO:0051248,negative regulation of protein metabolic process,M1,1,0
1,-2.3,GO:0016788,"hydrolase activity, acting on ester bonds",M1,1,0
1,-7.5,GO:0019955,cytokine binding,M1,1,0
1,-2.5,GO:0045334,clathrin-coated endocytic vesicle,M1,1,0
1,-4.4,GO:0002715,regulation of natural killer cell mediated immunity,M1,1,0
1,-2.7,GO:0062013,positive regulation of small molecule metabolic process,M1,1,0
1,-2.1,GO:0044291,cell-cell contact zone,M1,1,0
1,-2.4,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-3.7,GO:0048484,enteric nervous system development,M1,1,0
1,-2.6,GO:0004672,protein kinase activity,M1,1,0
1,-2.3,GO:0046889,positive regulation of lipid biosynthetic process,M1,1,0
1,-2.2,GO:0032588,trans-Golgi network membrane,M1,1,0
1,-2.2,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,M1,1,0
1,-3.8,GO:0032760,positive regulation of tumor necrosis factor production,M1,1,0
1,-3.2,GO:0023019,signal transduction involved in regulation of gene expression,M1,1,0
1,-2.6,GO:0001892,embryonic placenta development,M1,1,0
1,-2.6,GO:0098581,detection of external biotic stimulus,M1,1,0
1,-2.3,GO:0045664,regulation of neuron differentiation,M1,1,0
1,-8,GO:1903039,positive regulation of leukocyte cell-cell adhesion,M1,1,0
1,-3,GO:0031623,receptor internalization,M1,1,0
1,-2.5,GO:0030851,granulocyte differentiation,M1,1,0
1,-2.8,GO:1902106,negative regulation of leukocyte differentiation,M1,1,0
1,-4.8,GO:0098771,inorganic ion homeostasis,M1,1,0
1,-4.6,GO:0050777,negative regulation of immune response,M1,1,0
1,-2.5,GO:0048565,digestive tract development,M1,1,0
1,-2.3,GO:1903531,negative regulation of secretion by cell,M1,1,0
1,-2.2,GO:0030258,lipid modification,M1,1,0
1,-2,GO:0015850,organic hydroxy compound transport,M1,1,0
1,-2.6,GO:0007565,female pregnancy,M1,1,0
1,-5.1,GO:0098576,lumenal side of membrane,M1,1,0
1,-2.5,GO:0060337,type I interferon-mediated signaling pathway,M1,1,0
1,-2.9,GO:0019220,regulation of phosphate metabolic process,M1,1,0
1,-2.1,GO:0055078,sodium ion homeostasis,M1,1,0
1,-3.9,GO:0001763,morphogenesis of a branching structure,M1,1,0
1,-2.1,GO:1901890,positive regulation of cell junction assembly,M1,1,0
1,-2,GO:0032733,positive regulation of interleukin-10 production,M1,1,0
1,-7.4,GO:0050921,positive regulation of chemotaxis,M1,1,0
1,-2.6,GO:0001934,positive regulation of protein phosphorylation,M1,1,0
1,-4,GO:0070661,leukocyte proliferation,M1,1,0
1,-3.7,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,M1,1,0
1,-3.4,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,M1,1,0
1,-4.6,GO:0048010,vascular endothelial growth factor receptor signaling pathway,M1,1,0
1,-2,GO:0002714,positive regulation of B cell mediated immunity,M1,1,0
1,-2.9,GO:0043271,negative regulation of monoatomic ion transport,M1,1,0
1,-3,GO:0002218,activation of innate immune response,M1,1,0
1,-4.2,GO:0002250,adaptive immune response,M1,1,0
1,-2.2,GO:0043604,amide biosynthetic process,M1,1,0
1,-2.9,GO:0034341,response to type II interferon,M1,1,0
1,-3,GO:0071675,regulation of mononuclear cell migration,M1,1,0
1,-2.2,GO:0005509,calcium ion binding,M1,1,0
1,-4.4,GO:0001875,lipopolysaccharide immune receptor activity,M1,1,0
1,-2,GO:0016049,cell growth,M1,1,0
1,-4.2,GO:0042100,B cell proliferation,M1,1,0
1,-5.7,GO:0023023,MHC protein complex binding,M1,1,0
1,-3.5,GO:0001822,kidney development,M1,1,0
1,-7,GO:0042129,regulation of T cell proliferation,M1,1,0
1,-3.7,GO:0035590,purinergic nucleotide receptor signaling pathway,M1,1,0
1,-8.8,GO:0050863,regulation of T cell activation,M1,1,0
1,-2.8,GO:0038084,vascular endothelial growth factor signaling pathway,M1,1,0
1,-2.4,GO:0051336,regulation of hydrolase activity,M1,1,0
1,-2.3,GO:0016485,protein processing,M1,1,0
1,-4.2,GO:0050672,negative regulation of lymphocyte proliferation,M1,1,0
1,-3.1,GO:0002832,negative regulation of response to biotic stimulus,M1,1,0
1,-2.8,GO:0046636,negative regulation of alpha-beta T cell activation,M1,1,0
1,-2.6,GO:0030133,transport vesicle,M1,1,0
1,-3,GO:0005496,steroid binding,M1,1,0
1,-6.6,GO:0008285,negative regulation of cell population proliferation,M1,1,0
1,-2,GO:0051092,positive regulation of NF-kappaB transcription factor activity,M1,1,0
1,-2.6,GO:0008157,protein phosphatase 1 binding,M1,1,0
1,-8.8,GO:0019838,growth factor binding,M1,1,0
1,-4,GO:0120162,positive regulation of cold-induced thermogenesis,M1,1,0
1,-3.3,GO:0072001,renal system development,M1,1,0
1,-4,GO:0002501,peptide antigen assembly with MHC protein complex,M1,1,0
1,-3,GO:0140352,export from cell,M1,1,0
1,-2.1,GO:0048588,developmental cell growth,M1,1,0
1,-2.3,GO:0002763,positive regulation of myeloid leukocyte differentiation,M1,1,0
1,-2.7,GO:0007422,peripheral nervous system development,M1,1,0
1,-2.7,GO:0045591,positive regulation of regulatory T cell differentiation,M1,1,0
1,-4.8,GO:0019883,antigen processing and presentation of endogenous antigen,M1,1,0
1,-4.5,GO:0002285,lymphocyte activation involved in immune response,M1,1,0
1,-3.7,GO:0019902,phosphatase binding,M1,1,0
1,-3,GO:0098543,detection of other organism,M1,1,0
1,-2.3,GO:0060070,canonical Wnt signaling pathway,M1,1,0
1,-3.7,GO:0045662,negative regulation of myoblast differentiation,M1,1,0
1,-4.2,GO:2000564,"regulation of CD8-positive, alpha-beta T cell proliferation",M1,1,0
1,-2.4,GO:0071889,14-3-3 protein binding,M1,1,0
1,-2.7,GO:0043542,endothelial cell migration,M1,1,0
1,-5.4,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",M1,1,0
1,-3.2,GO:0098802,plasma membrane signaling receptor complex,M1,1,0
1,-2.3,GO:0046328,regulation of JNK cascade,M1,1,0
1,-7.5,GO:0045177,apical part of cell,M1,1,0
1,-3.6,GO:0042113,B cell activation,M1,1,0
1,-4,GO:0055080,monoatomic cation homeostasis,M1,1,0
1,-11,GO:0001944,vasculature development,M1,1,0
1,-2.4,GO:0046824,positive regulation of nucleocytoplasmic transport,M1,1,0
1,-5.8,GO:0001618,virus receptor activity,M1,1,0
1,-2.1,GO:0045589,regulation of regulatory T cell differentiation,M1,1,0
1,-2.2,GO:0045920,negative regulation of exocytosis,M1,1,0
1,-3.8,GO:0140303,intramembrane lipid transporter activity,M1,1,0
1,-2.7,GO:0071470,cellular response to osmotic stress,M1,1,0
1,-2.3,GO:0072009,nephron epithelium development,M1,1,0
1,-2.8,GO:0032720,negative regulation of tumor necrosis factor production,M1,1,0
1,-2.1,GO:0009595,detection of biotic stimulus,M1,1,0
1,-2.6,GO:0038187,pattern recognition receptor activity,M1,1,0
1,-5.8,GO:0031342,negative regulation of cell killing,M1,1,0
1,-3.6,GO:0051701,biological process involved in interaction with host,M1,1,0
1,-2.7,GO:0061440,kidney vasculature development,M1,1,0
1,-5.1,GO:0030099,myeloid cell differentiation,M1,1,0
1,-4.9,GO:0002009,morphogenesis of an epithelium,M1,1,0
1,-2.9,GO:0071402,cellular response to lipoprotein particle stimulus,M1,1,0
1,-2.5,GO:0016055,Wnt signaling pathway,M1,1,0
1,-4.4,GO:0002262,myeloid cell homeostasis,M1,1,0
1,-2.7,GO:0006873,intracellular monoatomic ion homeostasis,M1,1,0
1,-3.8,GO:0023026,MHC class II protein complex binding,M1,1,0
1,-2.9,GO:0021700,developmental maturation,M1,1,0
1,-2.3,GO:0032368,regulation of lipid transport,M1,1,0
1,-3.5,GO:1903038,negative regulation of leukocyte cell-cell adhesion,M1,1,0
1,-2.5,GO:0043087,regulation of GTPase activity,M1,1,0
1,-3.6,GO:0030218,erythrocyte differentiation,M1,1,0
1,-4.9,GO:0019884,antigen processing and presentation of exogenous antigen,M1,1,0
1,-2.4,GO:0120015,sterol transfer activity,M1,1,0
1,-5.3,GO:0019904,protein domain specific binding,M1,1,0
1,-2.1,GO:0004866,endopeptidase inhibitor activity,M1,1,0
1,-2.2,GO:0001916,positive regulation of T cell mediated cytotoxicity,M1,1,0
1,-5.2,GO:0048002,antigen processing and presentation of peptide antigen,M1,1,0
1,-4.3,GO:0010008,endosome membrane,M1,1,0
1,-2.5,GO:0098791,Golgi apparatus subcompartment,M1,1,0
1,-2.2,GO:0038034,signal transduction in absence of ligand,M1,1,0
1,-5.1,GO:0004896,cytokine receptor activity,M1,1,0
1,-3.8,GO:0019900,kinase binding,M1,1,0
1,-6.1,GO:0043068,positive regulation of programmed cell death,M1,1,0
1,-3.2,GO:0140115,export across plasma membrane,M1,1,0
1,-5.4,GO:0002478,antigen processing and presentation of exogenous peptide antigen,M1,1,0
1,-2.3,GO:0002443,leukocyte mediated immunity,M1,1,0
1,-2.5,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,M1,1,0
1,-3.9,GO:0050764,regulation of phagocytosis,M1,1,0
1,-2,GO:0043903,regulation of biological process involved in symbiotic interaction,M1,1,0
1,-3.9,GO:0050926,regulation of positive chemotaxis,M1,1,0
1,-2.2,GO:0070821,tertiary granule membrane,M1,1,0
1,-7,GO:0016324,apical plasma membrane,M1,1,0
1,-15,GO:0009897,external side of plasma membrane,M1,1,0
1,-2.6,GO:0042984,regulation of amyloid precursor protein biosynthetic process,M1,1,0
1,-4.1,GO:0050790,regulation of catalytic activity,M1,1,0
1,-2.6,GO:1903306,negative regulation of regulated secretory pathway,M1,1,0
1,-3.5,GO:0030111,regulation of Wnt signaling pathway,M1,1,0
1,-4.4,GO:0032835,glomerulus development,M1,1,0
1,-2.5,GO:0061008,hepaticobiliary system development,M1,1,0
1,-5.1,GO:0060586,multicellular organismal-level iron ion homeostasis,M1,1,0
1,-5.2,GO:0044093,positive regulation of molecular function,M1,1,0
1,-3.5,GO:0043434,response to peptide hormone,M1,1,0
1,-7.1,GO:0070633,transepithelial transport,M1,1,0
1,-4.6,GO:0062012,regulation of small molecule metabolic process,M1,1,0
1,-4.3,GO:0071560,cellular response to transforming growth factor beta stimulus,M1,1,0
1,-3.1,GO:0001707,mesoderm formation,M1,1,0
1,-2.6,GO:2000209,regulation of anoikis,M1,1,0
1,-2.2,GO:0045577,regulation of B cell differentiation,M1,1,0
1,-3.9,GO:0002263,cell activation involved in immune response,M1,1,0
1,-2.6,GO:0004857,enzyme inhibitor activity,M1,1,0
1,-4.5,GO:0044409,symbiont entry into host,M1,1,0
1,-6.5,GO:0032757,positive regulation of interleukin-8 production,M1,1,0
1,-2.2,GO:0031663,lipopolysaccharide-mediated signaling pathway,M1,1,0
1,-2.3,GO:0090022,regulation of neutrophil chemotaxis,M1,1,0
1,-2.4,GO:0042633,hair cycle,M1,1,0
1,-2.8,GO:0030165,PDZ domain binding,M1,1,0
1,-2.3,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M1,1,0
1,-6.7,GO:0050867,positive regulation of cell activation,M1,1,0
1,-3.3,GO:0071677,positive regulation of mononuclear cell migration,M1,1,0
1,-2.3,GO:0071634,regulation of transforming growth factor beta production,M1,1,0
1,-2,GO:0030510,regulation of BMP signaling pathway,M1,1,0
1,-4,GO:0002698,negative regulation of immune effector process,M1,1,0
1,-2.6,GO:0002886,regulation of myeloid leukocyte mediated immunity,M1,1,0
1,-2.9,GO:0044703,multi-organism reproductive process,M1,1,0
1,-3.8,GO:0072089,stem cell proliferation,M1,1,0
1,-6.9,GO:1902105,regulation of leukocyte differentiation,M1,1,0
1,-4.8,GO:0032729,positive regulation of type II interferon production,M1,1,0
1,-2.6,GO:1901699,cellular response to nitrogen compound,M1,1,0
1,-5.1,GO:0060100,"positive regulation of phagocytosis, engulfment",M1,1,0
1,-2.9,GO:0071216,cellular response to biotic stimulus,M1,1,0
1,-6.4,GO:1903131,mononuclear cell differentiation,M1,1,0
1,-2.8,GO:0046637,regulation of alpha-beta T cell differentiation,M1,1,0
1,-2.8,GO:0061318,renal filtration cell differentiation,M1,1,0
1,-4.1,GO:0048708,astrocyte differentiation,M1,1,0
1,-4.4,GO:0032680,regulation of tumor necrosis factor production,M1,1,0
1,-4,GO:0019216,regulation of lipid metabolic process,M1,1,0
1,-13,GO:0030335,positive regulation of cell migration,M1,1,0
1,-2.4,GO:0002230,positive regulation of defense response to virus by host,M1,1,0
1,-2.1,GO:0045807,positive regulation of endocytosis,M1,1,0
1,-3.5,GO:0042330,taxis,M1,1,0
1,-2.9,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M1,1,0
1,-3.3,GO:0030856,regulation of epithelial cell differentiation,M1,1,0
1,-3.9,GO:0001914,regulation of T cell mediated cytotoxicity,M1,1,0
1,-4.2,GO:0034101,erythrocyte homeostasis,M1,1,0
1,-3.1,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,M1,1,0
1,-2.7,GO:0060008,Sertoli cell differentiation,M1,1,0
1,-2.3,GO:0043010,camera-type eye development,M1,1,0
1,-12,GO:0001568,blood vessel development,M1,1,0
1,-6.5,GO:0002720,positive regulation of cytokine production involved in immune response,M1,1,0
1,-7.2,GO:0050878,regulation of body fluid levels,M1,1,0
1,-3.7,GO:0071214,cellular response to abiotic stimulus,M1,1,0
1,-2.8,GO:0150063,visual system development,M1,1,0
1,-2.7,GO:1901201,regulation of extracellular matrix assembly,M1,1,0
1,-2.6,GO:0060541,respiratory system development,M1,1,0
1,-3.4,GO:0045599,negative regulation of fat cell differentiation,M1,1,0
1,-2.3,GO:0110110,positive regulation of animal organ morphogenesis,M1,1,0
1,-5.5,GO:0051607,defense response to virus,M1,1,0
1,-5,GO:1900046,regulation of hemostasis,M1,1,0
1,-2.3,GO:0061135,endopeptidase regulator activity,M1,1,0
1,-4.6,GO:0031253,cell projection membrane,M1,1,0
1,-7.7,GO:0050778,positive regulation of immune response,M1,1,0
1,-2.3,GO:0070374,positive regulation of ERK1 and ERK2 cascade,M1,1,0
1,-2.8,GO:0032700,negative regulation of interleukin-17 production,M1,1,0
1,-8.8,GO:0150104,transport across blood-brain barrier,M1,1,0
1,-2.6,GO:1901654,response to ketone,M1,1,0
1,-4,GO:0031349,positive regulation of defense response,M1,1,0
1,-2.5,GO:1900745,positive regulation of p38MAPK cascade,M1,1,0
1,-2.5,GO:0009896,positive regulation of catabolic process,M1,1,0
1,-2.9,GO:0019752,carboxylic acid metabolic process,M1,1,0
1,-3.6,GO:0048469,cell maturation,M1,1,0
1,-2.5,GO:0008305,integrin complex,M1,1,0
1,-2,GO:0016053,organic acid biosynthetic process,M1,1,0
1,-2.3,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,M1,1,0
1,-2.1,GO:0046394,carboxylic acid biosynthetic process,M1,1,0
1,-4,GO:0022408,negative regulation of cell-cell adhesion,M1,1,0
1,-2.4,GO:0042303,molting cycle,M1,1,0
1,-3,GO:0002711,positive regulation of T cell mediated immunity,M1,1,0
1,-3,GO:0046457,prostanoid biosynthetic process,M1,1,0
1,-2.9,GO:0046850,regulation of bone remodeling,M1,1,0
1,-3.7,GO:0060249,anatomical structure homeostasis,M1,1,0
1,-2.4,GO:0032648,regulation of interferon-beta production,M1,1,0
1,-5.6,GO:0098857,membrane microdomain,M1,1,0
1,-2.8,GO:0008610,lipid biosynthetic process,M1,1,0
1,-3.4,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M1,1,0
1,-4.7,GO:0042269,regulation of natural killer cell mediated cytotoxicity,M1,1,0
1,-2.2,GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2,GO:0016486,peptide hormone processing,M1,1,0
1,-2.6,GO:0035270,endocrine system development,M1,1,0
1,-3.7,GO:0046651,lymphocyte proliferation,M1,1,0
1,-2.2,GO:0032651,regulation of interleukin-1 beta production,M1,1,0
1,-6,GO:0002718,regulation of cytokine production involved in immune response,M1,1,0
1,-2.1,GO:1901655,cellular response to ketone,M1,1,0
1,-4.1,GO:0021932,hindbrain radial glia guided cell migration,M1,1,0
1,-3.8,GO:0002224,toll-like receptor signaling pathway,M1,1,0
1,-3.2,GO:0032653,regulation of interleukin-10 production,M1,1,0
1,-2.3,GO:0002221,pattern recognition receptor signaling pathway,M1,1,0
1,-3.9,GO:0033559,unsaturated fatty acid metabolic process,M1,1,0
1,-3.6,GO:0042581,specific granule,M1,1,0
1,-2.1,GO:0005667,transcription regulator complex,M1,1,0
1,-2,GO:0044331,cell-cell adhesion mediated by cadherin,M1,1,0
1,-3.9,GO:0002253,activation of immune response,M1,1,0
1,-7,GO:0002696,positive regulation of leukocyte activation,M1,1,0
1,-2.6,GO:2000737,negative regulation of stem cell differentiation,M1,1,0
1,-2.2,GO:0044092,negative regulation of molecular function,M1,1,0
1,-3,GO:0001614,purinergic nucleotide receptor activity,M1,1,0
1,-11,GO:0045785,positive regulation of cell adhesion,M1,1,0
1,-5.6,GO:0048732,gland development,M1,1,0
1,-3.9,GO:0030195,negative regulation of blood coagulation,M1,1,0
1,-2.9,GO:0014032,neural crest cell development,M1,1,0
1,-2.2,GO:0031343,positive regulation of cell killing,M1,1,0
1,-4.4,GO:0004714,transmembrane receptor protein tyrosine kinase activity,M1,1,0
1,-3.3,GO:2000106,regulation of leukocyte apoptotic process,M1,1,0
1,-5.7,GO:0001701,in utero embryonic development,M1,1,0
1,-3.1,GO:0060760,positive regulation of response to cytokine stimulus,M1,1,0
1,-2.7,GO:0031252,cell leading edge,M1,1,0
1,-3.2,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",M1,1,0
1,-3.5,GO:0045028,G protein-coupled purinergic nucleotide receptor activity,M1,1,0
1,-2.8,GO:0072112,podocyte differentiation,M1,1,0
1,-4.5,GO:0002764,immune response-regulating signaling pathway,M1,1,0
1,-2.8,GO:0033691,sialic acid binding,M1,1,0
1,-4.3,GO:2000630,positive regulation of miRNA metabolic process,M1,1,0
1,-4,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,M1,1,0
1,-2.1,GO:0007219,Notch signaling pathway,M1,1,0
1,-2.2,GO:0043535,regulation of blood vessel endothelial cell migration,M1,1,0
1,-3.7,GO:0071622,regulation of granulocyte chemotaxis,M1,1,0
1,-3.6,GO:1902895,positive regulation of miRNA transcription,M1,1,0
1,-3,GO:1903829,positive regulation of protein localization,M1,1,0
1,-2.6,GO:0002762,negative regulation of myeloid leukocyte differentiation,M1,1,0
1,-4.5,GO:0045088,regulation of innate immune response,M1,1,0
1,-3.9,GO:0016032,viral process,M1,1,0
1,-4.7,GO:0010876,lipid localization,M1,1,0
1,-2.1,GO:0042287,MHC protein binding,M1,1,0
1,-2.7,GO:0048821,erythrocyte development,M1,1,0
1,-3.1,GO:0043583,ear development,M1,1,0
1,-2,GO:0030031,cell projection assembly,M1,1,0
1,-2.9,GO:0048562,embryonic organ morphogenesis,M1,1,0
1,-5.7,GO:0061041,regulation of wound healing,M1,1,0
1,-4.4,GO:0032649,regulation of type II interferon production,M1,1,0
1,-10,GO:0009611,response to wounding,M1,1,0
1,-3.9,GO:0071260,cellular response to mechanical stimulus,M1,1,0
1,-3.1,GO:0001649,osteoblast differentiation,M1,1,0
1,-3.3,GO:0002399,MHC class II protein complex assembly,M1,1,0
1,-6.8,GO:0042611,MHC protein complex,M1,1,0
1,-3.6,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",M1,1,0
1,-2.1,GO:0032732,positive regulation of interleukin-1 production,M1,1,0
1,-5.9,GO:0098553,lumenal side of endoplasmic reticulum membrane,M1,1,0
1,-2.6,GO:0014033,neural crest cell differentiation,M1,1,0
1,-3.4,GO:0035655,interleukin-18-mediated signaling pathway,M1,1,0
1,-2.9,GO:0061351,neural precursor cell proliferation,M1,1,0
1,-6.2,GO:0046634,regulation of alpha-beta T cell activation,M1,1,0
1,-2.7,GO:0072311,glomerular epithelial cell differentiation,M1,1,0
1,-2.2,GO:0030027,lamellipodium,M1,1,0
1,-5.4,GO:0050671,positive regulation of lymphocyte proliferation,M1,1,0
1,-6.5,GO:0002702,positive regulation of production of molecular mediator of immune response,M1,1,0
1,-6.1,GO:0050817,coagulation,M1,1,0
1,-3.1,GO:0002833,positive regulation of response to biotic stimulus,M1,1,0
1,-2.6,GO:0045296,cadherin binding,M1,1,0
1,-4.3,GO:0002688,regulation of leukocyte chemotaxis,M1,1,0
1,-2.6,GO:0030325,adrenal gland development,M1,1,0
1,-3.7,GO:0006631,fatty acid metabolic process,M1,1,0
1,-12,GO:0002694,regulation of leukocyte activation,M1,1,0
1,-3.9,GO:0009612,response to mechanical stimulus,M1,1,0
1,-3.8,GO:1901203,positive regulation of extracellular matrix assembly,M1,1,0
1,-6.8,GO:0050866,negative regulation of cell activation,M1,1,0
1,-6.4,GO:0008134,transcription factor binding,M1,1,0
1,-2.1,GO:0045124,regulation of bone resorption,M1,1,0
1,-2.1,GO:0016202,regulation of striated muscle tissue development,M1,1,0
1,-3.8,GO:0000165,MAPK cascade,M1,1,0
1,-3.3,GO:0002286,T cell activation involved in immune response,M1,1,0
1,-2.3,GO:0042327,positive regulation of phosphorylation,M1,1,0
1,-2.3,GO:0005834,heterotrimeric G-protein complex,M1,1,0
1,-3,GO:0016502,nucleotide receptor activity,M1,1,0
1,-2.2,GO:0043254,regulation of protein-containing complex assembly,M1,1,0
1,-2.2,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",M1,1,0
1,-2,GO:0010810,regulation of cell-substrate adhesion,M1,1,0
1,-8.8,GO:0010232,vascular transport,M1,1,0
1,-3.2,GO:0071219,cellular response to molecule of bacterial origin,M1,1,0
1,-3.1,GO:0008013,beta-catenin binding,M1,1,0
1,-4,GO:0030175,filopodium,M1,1,0
1,-3.1,GO:0022612,gland morphogenesis,M1,1,0
1,-2.4,GO:0043255,regulation of carbohydrate biosynthetic process,M1,1,0
1,-2.3,GO:0001938,positive regulation of endothelial cell proliferation,M1,1,0
1,-2.7,GO:0090023,positive regulation of neutrophil chemotaxis,M1,1,0
1,-4.7,GO:0061809,"NAD+ nucleosidase activity, cyclic ADP-ribose generating",M1,1,0
1,-4,GO:0002237,response to molecule of bacterial origin,M1,1,0
1,-2.1,GO:0032365,intracellular lipid transport,M1,1,0
1,-2.4,GO:0002712,regulation of B cell mediated immunity,M1,1,0
1,-2.7,GO:0050927,positive regulation of positive chemotaxis,M1,1,0
1,-2.9,GO:0006690,icosanoid metabolic process,M1,1,0
1,-3.2,GO:0030168,platelet activation,M1,1,0
1,-3.2,GO:0042325,regulation of phosphorylation,M1,1,0
1,-4.3,GO:0012507,ER to Golgi transport vesicle membrane,M1,1,0
1,-3.5,GO:1903707,negative regulation of hemopoiesis,M1,1,0
1,-3.5,GO:0006909,phagocytosis,M1,1,0
1,-4.1,GO:0046640,regulation of alpha-beta T cell proliferation,M1,1,0
1,-2.3,GO:1902624,positive regulation of neutrophil migration,M1,1,0
1,-2.1,GO:0050679,positive regulation of epithelial cell proliferation,M1,1,0
1,-5.7,GO:0033218,amide binding,M1,1,0
1,-2.2,GO:0071222,cellular response to lipopolysaccharide,M1,1,0
1,-3.5,GO:0070820,tertiary granule,M1,1,0
1,-3.5,GO:0045582,positive regulation of T cell differentiation,M1,1,0
1,-3.9,GO:0002028,regulation of sodium ion transport,M1,1,0
1,-2.1,GO:0060326,cell chemotaxis,M1,1,0
1,-3.5,GO:0006935,chemotaxis,M1,1,0
1,-3.7,GO:0001932,regulation of protein phosphorylation,M1,1,0
1,-2.1,GO:0150116,regulation of cell-substrate junction organization,M1,1,0
1,-5.2,GO:0006972,hyperosmotic response,M1,1,0
1,-4,GO:0002396,MHC protein complex assembly,M1,1,0
1,-5.2,GO:0002716,negative regulation of natural killer cell mediated immunity,M1,1,0
1,-4,GO:0031348,negative regulation of defense response,M1,1,0
1,-2,GO:0015748,organophosphate ester transport,M1,1,0
1,-3.1,GO:0016773,"phosphotransferase activity, alcohol group as acceptor",M1,1,0
1,-3.8,GO:0001726,ruffle,M1,1,0
1,-3.5,GO:0001569,branching involved in blood vessel morphogenesis,M1,1,0
1,-2,GO:1902305,regulation of sodium ion transmembrane transport,M1,1,0
1,-3.1,GO:0071474,cellular hyperosmotic response,M1,1,0
1,-2.2,GO:0030662,coated vesicle membrane,M1,1,0
1,-2.5,GO:0004713,protein tyrosine kinase activity,M1,1,0
1,-3.3,GO:0030134,COPII-coated ER to Golgi transport vesicle,M1,1,0
1,-3.3,GO:0030135,coated vesicle,M1,1,0
1,-3.6,GO:0071695,anatomical structure maturation,M1,1,0
1,-2.3,GO:0035019,somatic stem cell population maintenance,M1,1,0
1,-2.2,GO:0060042,retina morphogenesis in camera-type eye,M1,1,0
1,-15,GO:0035239,tube morphogenesis,M1,1,0
1,-5.9,GO:0030139,endocytic vesicle,M1,1,0
1,-2.5,GO:1905952,regulation of lipid localization,M1,1,0
1,-4.8,GO:0042102,positive regulation of T cell proliferation,M1,1,0
1,-2.1,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.8,GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",M1,1,0
1,-3.7,GO:0017046,peptide hormone binding,M1,1,0
1,-5.4,GO:0005319,lipid transporter activity,M1,1,0
1,-2.2,GO:1903900,regulation of viral life cycle,M1,1,0
1,-2.8,GO:0036293,response to decreased oxygen levels,M1,1,0
1,-2.4,GO:0072210,metanephric nephron development,M1,1,0
1,-2.8,GO:0035924,cellular response to vascular endothelial growth factor stimulus,M1,1,0
1,-3.1,GO:0002724,regulation of T cell cytokine production,M1,1,0
1,-2.9,GO:0003725,double-stranded RNA binding,M1,1,0
1,-3.7,GO:0050819,negative regulation of coagulation,M1,1,0
1,-3.2,GO:1903522,regulation of blood circulation,M1,1,0
1,-2.5,GO:1905523,positive regulation of macrophage migration,M1,1,0
1,-4.9,GO:1902893,regulation of miRNA transcription,M1,1,0
1,-6.5,GO:0002695,negative regulation of leukocyte activation,M1,1,0
1,-3.4,GO:0098739,import across plasma membrane,M1,1,0
1,-2.1,GO:0051604,protein maturation,M1,1,0
1,-2.5,GO:0051894,positive regulation of focal adhesion assembly,M1,1,0
1,-5.9,GO:0002064,epithelial cell development,M1,1,0
1,-2.5,GO:0052372,modulation by symbiont of entry into host,M1,1,0
1,-3.9,GO:0048332,mesoderm morphogenesis,M1,1,0
1,-4,GO:0032755,positive regulation of interleukin-6 production,M1,1,0
1,-4.5,GO:0045766,positive regulation of angiogenesis,M1,1,0
1,-2.9,GO:0001666,response to hypoxia,M1,1,0
1,-2.8,GO:0009410,response to xenobiotic stimulus,M1,1,0
1,-2.6,GO:0010811,positive regulation of cell-substrate adhesion,M1,1,0
1,-2.1,GO:0008016,regulation of heart contraction,M1,1,0
1,-4,GO:0002483,antigen processing and presentation of endogenous peptide antigen,M1,1,0
1,-2.4,GO:0060603,mammary gland duct morphogenesis,M1,1,0
1,-2.6,GO:0072010,glomerular epithelium development,M1,1,0
1,-2.1,GO:0051223,regulation of protein transport,M1,1,0
1,-2.1,GO:0016887,ATP hydrolysis activity,M1,1,0
1,-2,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-4.8,GO:0071496,cellular response to external stimulus,M1,1,0
1,-2.5,GO:0006468,protein phosphorylation,M1,1,0
1,-2.7,GO:0002758,innate immune response-activating signaling pathway,M1,1,0
1,-2.6,GO:0072132,mesenchyme morphogenesis,M1,1,0
1,-2.6,GO:0035051,cardiocyte differentiation,M1,1,0
1,-2.2,GO:0060759,regulation of response to cytokine stimulus,M1,1,0
1,-2.8,GO:0035296,regulation of tube diameter,M1,1,0
1,-2,GO:0048589,developmental growth,M1,1,0
1,-3.4,GO:0035589,G protein-coupled purinergic nucleotide receptor signaling pathway,M1,1,0
1,-2.5,GO:0072073,kidney epithelium development,M1,1,0
1,-2.6,GO:1900048,positive regulation of hemostasis,M1,1,0
1,-2.9,GO:0048839,inner ear development,M1,1,0
1,-2.4,GO:0070542,response to fatty acid,M1,1,0
1,-2.2,GO:0002429,immune response-activating cell surface receptor signaling pathway,M1,1,0
1,-6.1,GO:0007596,blood coagulation,M1,1,0
1,-3.2,GO:0034340,response to type I interferon,M1,1,0
1,-6.7,GO:0001819,positive regulation of cytokine production,M1,1,0
1,-5.3,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M1,1,0
1,-4.8,GO:0002709,regulation of T cell mediated immunity,M1,1,0
1,-8.1,GO:0070663,regulation of leukocyte proliferation,M1,1,0
1,-4.1,GO:0060485,mesenchyme development,M1,1,0
1,-5.2,GO:0002707,negative regulation of lymphocyte mediated immunity,M1,1,0
1,-3.7,GO:0104004,cellular response to environmental stimulus,M1,1,0
1,-4.6,GO:0071385,cellular response to glucocorticoid stimulus,M1,1,0
1,-4.4,GO:0005021,vascular endothelial growth factor receptor activity,M1,1,0
1,-3.4,GO:0045765,regulation of angiogenesis,M1,1,0
1,-2.5,GO:1903055,positive regulation of extracellular matrix organization,M1,1,0
1,-4.1,GO:0042445,hormone metabolic process,M1,1,0
1,-4.7,GO:0036324,vascular endothelial growth factor receptor-2 signaling pathway,M1,1,0
1,-3.8,GO:0042472,inner ear morphogenesis,M1,1,0
1,-7.7,GO:0006897,endocytosis,M1,1,0
1,-3.3,GO:0007498,mesoderm development,M1,1,0
1,-5.8,GO:0032677,regulation of interleukin-8 production,M1,1,0
1,-2.5,GO:0008360,regulation of cell shape,M1,1,0
1,-5.3,GO:0001216,DNA-binding transcription activator activity,M1,1,0
1,-4.7,GO:0002704,negative regulation of leukocyte mediated immunity,M1,1,0
1,-3.8,GO:0007162,negative regulation of cell adhesion,M1,1,0
1,-3.9,GO:0030890,positive regulation of B cell proliferation,M1,1,0
1,-5,GO:0002761,regulation of myeloid leukocyte differentiation,M1,1,0
1,-2.4,GO:0002449,lymphocyte mediated immunity,M1,1,0
1,-2.2,GO:0048008,platelet-derived growth factor receptor signaling pathway,M1,1,0
1,-3.2,GO:0030852,regulation of granulocyte differentiation,M1,1,0
1,-4.6,GO:0002831,regulation of response to biotic stimulus,M1,1,0
1,-2.9,GO:0097191,extrinsic apoptotic signaling pathway,M1,1,0
1,-5.8,GO:0030246,carbohydrate binding,M1,1,0
1,-3.1,GO:0072562,blood microparticle,M1,1,0
1,-4,GO:0002366,leukocyte activation involved in immune response,M1,1,0
1,-2.2,GO:0031334,positive regulation of protein-containing complex assembly,M1,1,0
1,-5.1,GO:1905155,positive regulation of membrane invagination,M1,1,0
1,-2.2,GO:0050767,regulation of neurogenesis,M1,1,0
1,-5.1,GO:0030247,polysaccharide binding,M1,1,0
1,-3.4,GO:0010743,regulation of macrophage derived foam cell differentiation,M1,1,0
1,-2.8,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",M1,1,0
1,-2.1,GO:0071404,cellular response to low-density lipoprotein particle stimulus,M1,1,0
1,-2.4,GO:1903825,organic acid transmembrane transport,M1,1,0
1,-3.8,GO:0044057,regulation of system process,M1,1,0
1,-2,GO:0043536,positive regulation of blood vessel endothelial cell migration,M1,1,0
1,-3.3,GO:1901342,regulation of vasculature development,M1,1,0
1,-2.6,GO:1902894,negative regulation of miRNA transcription,M1,1,0
1,-2.5,GO:0031399,regulation of protein modification process,M1,1,0
1,-4.2,GO:0090596,sensory organ morphogenesis,M1,1,0
1,-5.4,GO:0010710,regulation of collagen catabolic process,M1,1,0
1,-3.1,GO:0006109,regulation of carbohydrate metabolic process,M1,1,0
1,-2.2,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,M1,1,0
1,-4.1,GO:0008202,steroid metabolic process,M1,1,0
1,-2.1,GO:0006366,transcription by RNA polymerase II,M1,1,0
1,-4.6,GO:0042613,MHC class II protein complex,M1,1,0
1,-5.7,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,M1,1,0
1,-3.2,GO:0060009,Sertoli cell development,M1,1,0
1,-2.2,GO:0010562,positive regulation of phosphorus metabolic process,M1,1,0
1,-3.1,GO:0032642,regulation of chemokine production,M1,1,0
1,-2.4,GO:0061061,muscle structure development,M1,1,0
1,-4,GO:0016323,basolateral plasma membrane,M1,1,0
1,-4.3,GO:0046890,regulation of lipid biosynthetic process,M1,1,0
1,-4.4,GO:1904018,positive regulation of vasculature development,M1,1,0
1,-4.3,GO:0044042,glucan metabolic process,M1,1,0
1,-3.8,GO:0044062,regulation of excretion,M1,1,0
1,-2.1,GO:0032728,positive regulation of interferon-beta production,M1,1,0
1,-2.9,GO:0051174,regulation of phosphorus metabolic process,M1,1,0
1,-7.5,GO:0002706,regulation of lymphocyte mediated immunity,M1,1,0
1,-4.4,GO:0010935,regulation of macrophage cytokine production,M1,1,0
1,-3.9,GO:0051046,regulation of secretion,M1,1,0
1,-4.4,GO:1903708,positive regulation of hemopoiesis,M1,1,0
1,-2.9,GO:0043300,regulation of leukocyte degranulation,M1,1,0
1,-2.9,GO:0043401,steroid hormone receptor signaling pathway,M1,1,0
1,-2.8,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,M1,1,0
1,-3.8,GO:0050766,positive regulation of phagocytosis,M1,1,0
1,-5.9,GO:0010720,positive regulation of cell development,M1,1,0
1,-2.7,GO:0048864,stem cell development,M1,1,0
1,-5.7,GO:0070665,positive regulation of leukocyte proliferation,M1,1,0
1,-8,GO:0071383,cellular response to steroid hormone stimulus,M1,1,0
1,-3.6,GO:0050871,positive regulation of B cell activation,M1,1,0
1,-2,GO:0002520,immune system development,M1,1,0
1,-10,GO:0042060,wound healing,M1,1,0
1,-5.7,GO:0010817,regulation of hormone levels,M1,1,0
1,-3.6,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,M1,1,0
1,-2.3,GO:0090482,vitamin transmembrane transporter activity,M1,1,0
1,-3.4,GO:0035259,nuclear glucocorticoid receptor binding,M1,1,0
1,-2.6,GO:0051259,protein complex oligomerization,M1,1,0
1,-2.5,GO:2000629,negative regulation of miRNA metabolic process,M1,1,0
1,-2.3,GO:0055123,digestive system development,M1,1,0
1,-5.2,GO:0048872,homeostasis of number of cells,M1,1,0
1,-4.2,GO:0032945,negative regulation of mononuclear cell proliferation,M1,1,0
1,-7.2,GO:0140297,DNA-binding transcription factor binding,M1,1,0
1,-2,GO:0045429,positive regulation of nitric oxide biosynthetic process,M1,1,0
1,-3.1,GO:0045445,myoblast differentiation,M1,1,0
1,-5.3,GO:0009792,embryo development ending in birth or egg hatching,M1,1,0
1,-5.6,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,M1,1,0
1,-2.3,GO:0050869,negative regulation of B cell activation,M1,1,0
1,-6.7,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,M1,1,0
1,-4.2,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",M1,1,0
1,-2.4,GO:0090205,positive regulation of cholesterol metabolic process,M1,1,0
1,-3.7,GO:0042608,T cell receptor binding,M1,1,0
1,-7.8,GO:0098797,plasma membrane protein complex,M1,1,0
1,-3.9,GO:0030100,regulation of endocytosis,M1,1,0
1,-3.8,GO:0042130,negative regulation of T cell proliferation,M1,1,0
1,-3.7,GO:2000562,"negative regulation of CD4-positive, alpha-beta T cell proliferation",M1,1,0
1,-2.1,GO:0045670,regulation of osteoclast differentiation,M1,1,0
1,-2.7,GO:0005802,trans-Golgi network,M1,1,0
1,-5.4,GO:2000628,regulation of miRNA metabolic process,M1,1,0
1,-6.1,GO:0090554,phosphatidylcholine floppase activity,M1,1,0
1,-5.7,GO:0140272,exogenous protein binding,M1,1,0
1,-5.1,GO:1903035,negative regulation of response to wounding,M1,1,0
1,-2.5,GO:1903530,regulation of secretion by cell,M1,1,0
1,-7.5,GO:0002699,positive regulation of immune effector process,M1,1,0
1,-7.9,GO:0002683,negative regulation of immune system process,M1,1,0
1,-2.5,GO:0001968,fibronectin binding,M1,1,0
1,-2.2,GO:0051145,smooth muscle cell differentiation,M1,1,0
1,-2.1,GO:0035821,modulation of process of another organism,M1,1,0
1,-2.1,GO:1903036,positive regulation of response to wounding,M1,1,0
1,-2,GO:0017080,sodium channel regulator activity,M1,1,0
1,-2,GO:0000902,cell morphogenesis,M1,1,0
1,-2.1,GO:0043086,negative regulation of catalytic activity,M1,1,0
1,-4.7,GO:0006869,lipid transport,M1,1,0
1,-2.9,GO:0070294,renal sodium ion absorption,M1,1,0
1,-2.5,GO:0006939,smooth muscle contraction,M1,1,0
1,-2.5,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",M1,1,0
1,-2.3,GO:0019903,protein phosphatase binding,M1,1,0
1,-3.1,GO:0015914,phospholipid transport,M1,1,0
1,-6,GO:0070848,response to growth factor,M1,1,0
1,-3.7,GO:0042803,protein homodimerization activity,M1,1,0
1,-3.6,GO:0001540,amyloid-beta binding,M1,1,0
1,-3.5,GO:0019901,protein kinase binding,M1,1,0
1,-2.1,GO:0060323,head morphogenesis,M1,1,0
1,-3.3,GO:0010718,positive regulation of epithelial to mesenchymal transition,M1,1,0
1,-3.8,GO:0046943,carboxylic acid transmembrane transporter activity,M1,1,0
1,-3.2,GO:0048762,mesenchymal cell differentiation,M1,1,0
1,-3,GO:0042886,amide transport,M1,1,0
1,-2.8,GO:0001942,hair follicle development,M1,1,0
1,-7.3,GO:0042063,gliogenesis,M1,1,0
1,-2.5,GO:0002639,positive regulation of immunoglobulin production,M1,1,0
1,-2.3,GO:0031528,microvillus membrane,M1,1,0
1,-12,GO:2000147,positive regulation of cell motility,M1,1,0
1,-8,GO:0050670,regulation of lymphocyte proliferation,M1,1,0
1,-5,GO:0001910,regulation of leukocyte mediated cytotoxicity,M1,1,0
1,-3.3,GO:0010595,positive regulation of endothelial cell migration,M1,1,0
1,-2.2,GO:0014015,positive regulation of gliogenesis,M1,1,0
1,-2.2,GO:0003779,actin binding,M1,1,0
1,-4.5,GO:0007423,sensory organ development,M1,1,0
1,-2.8,GO:0035150,regulation of tube size,M1,1,0
1,-3.3,GO:0150117,positive regulation of cell-substrate junction organization,M1,1,0
1,-2.7,GO:0022405,hair cycle process,M1,1,0
1,-3.5,GO:0006814,sodium ion transport,M1,1,0
1,-2.2,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,M1,1,0
1,-2.1,GO:0019898,extrinsic component of membrane,M1,1,0
1,-7.5,GO:0022407,regulation of cell-cell adhesion,M1,1,0
1,-3.1,GO:0034764,positive regulation of transmembrane transport,M1,1,0
1,-3.1,GO:0008028,monocarboxylic acid transmembrane transporter activity,M1,1,0
1,-2.6,GO:0046638,positive regulation of alpha-beta T cell differentiation,M1,1,0
1,-2.9,GO:0030518,nuclear receptor-mediated steroid hormone signaling pathway,M1,1,0
1,-4.5,GO:0045648,positive regulation of erythrocyte differentiation,M1,1,0
1,-8.7,GO:0003013,circulatory system process,M1,1,0
1,-7.7,GO:0022409,positive regulation of cell-cell adhesion,M1,1,0
1,-6.6,GO:0048545,response to steroid hormone,M1,1,0
1,-2.5,GO:0070482,response to oxygen levels,M1,1,0
1,-2,GO:0001530,lipopolysaccharide binding,M1,1,0
1,-11,GO:0003018,vascular process in circulatory system,M1,1,0
1,-2,GO:0032892,positive regulation of organic acid transport,M1,1,0
1,-2.7,GO:0022404,molting cycle process,M1,1,0
1,-2.2,GO:0046677,response to antibiotic,M1,1,0
1,-4.1,GO:0051384,response to glucocorticoid,M1,1,0
1,-2.6,GO:0046903,secretion,M1,1,0
1,-4.4,GO:0050801,monoatomic ion homeostasis,M1,1,0
1,-2.6,GO:0001755,neural crest cell migration,M1,1,0
1,-5.3,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,M1,1,0
1,-3.9,GO:0060562,epithelial tube morphogenesis,M1,1,0
1,-2,GO:0048873,homeostasis of number of cells within a tissue,M1,1,0
1,-2.1,GO:0070873,regulation of glycogen metabolic process,M1,1,0
1,-3.4,GO:0005977,glycogen metabolic process,M1,1,0
1,-3.1,GO:0001503,ossification,M1,1,0
1,-3.8,GO:0140326,ATPase-coupled intramembrane lipid transporter activity,M1,1,0
1,-2.4,GO:0045335,phagocytic vesicle,M1,1,0
1,-3.9,GO:0002042,cell migration involved in sprouting angiogenesis,M1,1,0
1,-3.9,GO:0055038,recycling endosome membrane,M1,1,0
1,-2.9,GO:0001890,placenta development,M1,1,0
1,-3.7,GO:0045646,regulation of erythrocyte differentiation,M1,1,0
1,-3.8,GO:0006112,energy reserve metabolic process,M1,1,0
1,-4.9,GO:0050818,regulation of coagulation,M1,1,0
1,-2.2,GO:0006066,alcohol metabolic process,M1,1,0
1,-3.8,GO:2000739,regulation of mesenchymal stem cell differentiation,M1,1,0
1,-2.3,GO:0008217,regulation of blood pressure,M1,1,0
1,-4.5,GO:0043534,blood vessel endothelial cell migration,M1,1,0
1,-4,GO:0002757,immune response-activating signaling pathway,M1,1,0
1,-3.5,GO:0042045,epithelial fluid transport,M1,1,0
1,-2.8,GO:0030001,metal ion transport,M1,1,0
1,-2.7,GO:0061437,renal system vasculature development,M1,1,0
1,-12,GO:0040017,positive regulation of locomotion,M1,1,0
1,-2.6,GO:0043547,positive regulation of GTPase activity,M1,1,0
1,-6.6,GO:0071396,cellular response to lipid,M1,1,0
1,-3.3,GO:0040011,locomotion,M1,1,0
1,-11,GO:0051249,regulation of lymphocyte activation,M1,1,0
1,-4.8,GO:0002252,immune effector process,M1,1,0
1,-2.4,GO:0015026,coreceptor activity,M1,1,0
1,-2.1,GO:0046777,protein autophosphorylation,M1,1,0
1,-2.3,GO:0070167,regulation of biomineral tissue development,M1,1,0
1,-2.3,GO:0009914,hormone transport,M1,1,0
1,-4,GO:0010906,regulation of glucose metabolic process,M1,1,0
1,-2.3,GO:0071466,cellular response to xenobiotic stimulus,M1,1,0
1,-2.2,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,M1,1,0
1,-8.1,GO:0002521,leukocyte differentiation,M1,1,0
1,-3.4,GO:0071351,cellular response to interleukin-18,M1,1,0
1,-4.5,GO:0046718,symbiont entry into host cell,M1,1,0
1,-3.2,GO:0019229,regulation of vasoconstriction,M1,1,0
1,-2.1,GO:0042307,positive regulation of protein import into nucleus,M1,1,0
1,-4.3,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,M1,1,0
1,-9.7,GO:0046649,lymphocyte activation,M1,1,0
1,-4.7,GO:0010001,glial cell differentiation,M1,1,0
1,-3.2,GO:0097035,regulation of membrane lipid distribution,M1,1,0
1,-3.8,GO:0019199,transmembrane receptor protein kinase activity,M1,1,0
1,-2.6,GO:0001889,liver development,M1,1,0
1,-2,GO:0030864,cortical actin cytoskeleton,M1,1,0
1,-2.5,GO:0071357,cellular response to type I interferon,M1,1,0
1,-2.7,GO:0030667,secretory granule membrane,M1,1,0
1,-4.7,GO:0031341,regulation of cell killing,M1,1,0
1,-2.2,GO:0051260,protein homooligomerization,M1,1,0
1,-4.7,GO:0048598,embryonic morphogenesis,M1,1,0
1,-2.5,GO:1905039,carboxylic acid transmembrane transport,M1,1,0
1,-2.4,GO:0001664,G protein-coupled receptor binding,M1,1,0
1,-3.6,GO:0032943,mononuclear cell proliferation,M1,1,0
1,-6.7,GO:1903706,regulation of hemopoiesis,M1,1,0
1,-5.8,GO:0050727,regulation of inflammatory response,M1,1,0
1,-4.5,GO:0002687,positive regulation of leukocyte migration,M1,1,0
1,-2.6,GO:0034762,regulation of transmembrane transport,M1,1,0
1,-2.3,GO:0120013,lipid transfer activity,M1,1,0
1,-4.1,GO:0055037,recycling endosome,M1,1,0
1,-3.9,GO:0006636,unsaturated fatty acid biosynthetic process,M1,1,0
1,-4.2,GO:0002690,positive regulation of leukocyte chemotaxis,M1,1,0
1,-5.6,GO:0032675,regulation of interleukin-6 production,M1,1,0
1,-2.7,GO:0001221,transcription coregulator binding,M1,1,0
1,-2.3,GO:0043603,amide metabolic process,M1,1,0
1,-2.6,GO:0003823,antigen binding,M1,1,0
1,-2.5,GO:0042088,T-helper 1 type immune response,M1,1,0
1,-3.5,GO:0001704,formation of primary germ layer,M1,1,0
1,-4.2,GO:0042562,hormone binding,M1,1,0
1,-2.1,GO:0042044,fluid transport,M1,1,0
1,-2.1,GO:0010611,regulation of cardiac muscle hypertrophy,M1,1,0
1,-4,GO:0042605,peptide antigen binding,M1,1,0
1,-2.2,GO:1905332,positive regulation of morphogenesis of an epithelium,M1,1,0
1,-5.3,GO:0071384,cellular response to corticosteroid stimulus,M1,1,0
1,-2.5,GO:0016922,nuclear receptor binding,M1,1,0
1,-10,GO:0045321,leukocyte activation,M1,1,0
1,-2.6,GO:0030194,positive regulation of blood coagulation,M1,1,0
1,-3,GO:0002820,negative regulation of adaptive immune response,M1,1,0
1,-4,GO:0015711,organic anion transport,M1,1,0
1,-7.7,GO:0019221,cytokine-mediated signaling pathway,M1,1,0
1,-3.5,GO:0030666,endocytic vesicle membrane,M1,1,0
1,-3.2,GO:0048471,perinuclear region of cytoplasm,M1,1,0
1,-2.4,GO:0048754,branching morphogenesis of an epithelial tube,M1,1,0
1,-2.9,GO:0070293,renal absorption,M1,1,0
1,-6,GO:0007599,hemostasis,M1,1,0
1,-4.7,GO:0005769,early endosome,M1,1,0
1,-3.1,GO:0010594,regulation of endothelial cell migration,M1,1,0
1,-2.7,GO:0046641,positive regulation of alpha-beta T cell proliferation,M1,1,0
1,-5.1,GO:0048568,embryonic organ development,M1,1,0
1,-2.4,GO:0045834,positive regulation of lipid metabolic process,M1,1,0
1,-5.1,GO:0030193,regulation of blood coagulation,M1,1,0
1,-3,GO:0060216,definitive hemopoiesis,M1,1,0
1,-2.7,GO:0018212,peptidyl-tyrosine modification,M1,1,0
1,-6,GO:1900182,positive regulation of protein localization to nucleus,M1,1,0
1,-2.9,GO:0051345,positive regulation of hydrolase activity,M1,1,0
1,-2.1,GO:0140657,ATP-dependent activity,M1,1,0
1,-3.8,GO:0046645,positive regulation of gamma-delta T cell activation,M1,1,0
1,-5.8,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",M1,1,0
1,-5.3,GO:0002040,sprouting angiogenesis,M1,1,0
1,-4.5,GO:0009617,response to bacterium,M1,1,0
1,-4,GO:0045621,positive regulation of lymphocyte differentiation,M1,1,0
1,-4.7,GO:0098609,cell-cell adhesion,M1,1,0
1,-3.2,GO:0030331,nuclear estrogen receptor binding,M1,1,0
1,-2,GO:0002637,regulation of immunoglobulin production,M1,1,0
1,-5,GO:0050864,regulation of B cell activation,M1,1,0
1,-2.1,GO:0006692,prostanoid metabolic process,M1,1,0
1,-8.1,GO:1903037,regulation of leukocyte cell-cell adhesion,M1,1,0
1,-2.5,GO:0005902,microvillus,M1,1,0
1,-7.8,GO:0002703,regulation of leukocyte mediated immunity,M1,1,0
1,-3.3,GO:0051048,negative regulation of secretion,M1,1,0
1,-2.4,GO:0042578,phosphoric ester hydrolase activity,M1,1,0
1,-4.6,GO:0045637,regulation of myeloid cell differentiation,M1,1,0
1,-5.7,GO:0045121,membrane raft,M1,1,0
1,-3.4,GO:0035579,specific granule membrane,M1,1,0
1,-2.2,GO:0035850,epithelial cell differentiation involved in kidney development,M1,1,0
1,-2.5,GO:0050886,endocrine process,M1,1,0
1,-4.7,GO:0043269,regulation of monoatomic ion transport,M1,1,0
1,-2.3,GO:0090303,positive regulation of wound healing,M1,1,0
1,-2.6,GO:0030879,mammary gland development,M1,1,0
1,-2.8,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,M1,1,0
1,-12,GO:0050865,regulation of cell activation,M1,1,0
1,-9.2,GO:0006954,inflammatory response,M1,1,0
1,-3.9,GO:0000139,Golgi membrane,M1,1,0
1,-4.6,GO:0045619,regulation of lymphocyte differentiation,M1,1,0
1,-3.9,GO:0005548,phospholipid transporter activity,M1,1,0
1,-2,GO:1901861,regulation of muscle tissue development,M1,1,0
1,-3.7,GO:0030855,epithelial cell differentiation,M1,1,0
1,-2.4,GO:0002244,hematopoietic progenitor cell differentiation,M1,1,0
1,-2.3,GO:0001676,long-chain fatty acid metabolic process,M1,1,0
1,-3.1,GO:0003158,endothelium development,M1,1,0
1,-6,GO:0032102,negative regulation of response to external stimulus,M1,1,0
1,-7.3,GO:0050920,regulation of chemotaxis,M1,1,0
1,-2.2,GO:0003073,regulation of systemic arterial blood pressure,M1,1,0
1,-3.3,GO:0070673,response to interleukin-18,M1,1,0
1,-4.3,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",M1,1,0
1,-3.3,GO:0014829,vascular associated smooth muscle contraction,M1,1,0
1,-2.2,GO:0032006,regulation of TOR signaling,M1,1,0
1,-3.5,GO:0046942,carboxylic acid transport,M1,1,0
1,-5.4,GO:0060018,astrocyte fate commitment,M1,1,0
1,-3.5,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,M1,1,0
1,-2.1,GO:0014743,regulation of muscle hypertrophy,M1,1,0
1,-7,GO:0045596,negative regulation of cell differentiation,M1,1,0
1,-5.5,GO:0043009,chordate embryonic development,M1,1,0
1,-2.8,GO:0005925,focal adhesion,M1,1,0
1,-8.5,GO:0002697,regulation of immune effector process,M1,1,0
1,-3.2,GO:0060828,regulation of canonical Wnt signaling pathway,M1,1,0
1,-3.8,GO:0019725,cellular homeostasis,M1,1,0
1,-2.6,GO:0032753,positive regulation of interleukin-4 production,M1,1,0
1,-2.7,GO:0018108,peptidyl-tyrosine phosphorylation,M1,1,0
1,-2.2,GO:0010959,regulation of metal ion transport,M1,1,0
1,-2.7,GO:0030449,regulation of complement activation,M1,1,0
1,-2.3,GO:0141193,nuclear receptor-mediated signaling pathway,M1,1,0
1,-3.1,GO:0060055,angiogenesis involved in wound healing,M1,1,0
1,-2.1,GO:0003170,heart valve development,M1,1,0
1,-5.4,GO:0120161,regulation of cold-induced thermogenesis,M1,1,0
1,-3.3,GO:0061138,morphogenesis of a branching epithelium,M1,1,0
1,-2.3,GO:0016328,lateral plasma membrane,M1,1,0
1,-4.7,GO:0140328,floppase activity,M1,1,0
1,-4,GO:0045668,negative regulation of osteoblast differentiation,M1,1,0
1,-3.8,GO:0042908,xenobiotic transport,M1,1,0
1,-4.6,GO:0042593,glucose homeostasis,M1,1,0
1,-4.3,GO:0045667,regulation of osteoblast differentiation,M1,1,0
1,-4.9,GO:0060099,"regulation of phagocytosis, engulfment",M1,1,0
1,-2.9,GO:0044089,positive regulation of cellular component biogenesis,M1,1,0
1,-4.3,GO:0046631,alpha-beta T cell activation,M1,1,0
1,-3.7,GO:0019058,viral life cycle,M1,1,0
1,-3.4,GO:0034204,lipid translocation,M1,1,0
1,-3,GO:0014821,phasic smooth muscle contraction,M1,1,0
1,-2.5,GO:0002726,positive regulation of T cell cytokine production,M1,1,0
1,-5.7,GO:0043065,positive regulation of apoptotic process,M1,1,0
1,-2.9,GO:0035272,exocrine system development,M1,1,0
1,-2.1,GO:0030513,positive regulation of BMP signaling pathway,M1,1,0
1,-3.4,GO:0032673,regulation of interleukin-4 production,M1,1,0
1,-4.7,GO:0070371,ERK1 and ERK2 cascade,M1,1,0
1,-3.3,GO:0002503,peptide antigen assembly with MHC class II protein complex,M1,1,0
1,-3.3,GO:2000352,negative regulation of endothelial cell apoptotic process,M1,1,0
1,-2.8,GO:0097205,renal filtration,M1,1,0
1,-2.8,GO:0140359,ABC-type transporter activity,M1,1,0
1,-3.9,GO:0007507,heart development,M1,1,0
1,-2.7,GO:0098801,regulation of renal system process,M1,1,0
1,-2.4,GO:0046330,positive regulation of JNK cascade,M1,1,0
1,-3.5,GO:0015849,organic acid transport,M1,1,0
1,-5.3,GO:0007169,cell surface receptor protein tyrosine kinase signaling pathway,M1,1,0
1,-2.3,GO:0032731,positive regulation of interleukin-1 beta production,M1,1,0
1,-2.2,GO:0034330,cell junction organization,M1,1,0
1,-2.5,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,M1,1,0
1,-3.2,GO:0098858,actin-based cell projection,M1,1,0
1,-3.3,GO:0008514,organic anion transmembrane transporter activity,M1,1,0
1,-2.8,GO:0043085,positive regulation of catalytic activity,M1,1,0
1,-2.1,GO:0140888,interferon-mediated signaling pathway,M1,1,0
1,-2.2,GO:0009898,cytoplasmic side of plasma membrane,M1,1,0
1,-5,GO:0061045,negative regulation of wound healing,M1,1,0
1,-3.5,GO:0031994,insulin-like growth factor I binding,M1,1,0
1,-2.2,GO:0045937,positive regulation of phosphate metabolic process,M1,1,0
1,-3.8,GO:1900047,negative regulation of hemostasis,M1,1,0
1,-2.8,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,M1,1,0
1,-3,GO:0001501,skeletal system development,M1,1,0
1,-4,GO:0019882,antigen processing and presentation,M1,1,0
1,-3.5,GO:2000107,negative regulation of leukocyte apoptotic process,M1,1,0
1,-2.6,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,M1,1,0
1,-3.4,GO:0051051,negative regulation of transport,M1,1,0
1,-2.2,GO:0035456,response to interferon-beta,M1,1,0
1,-8.3,GO:0042110,T cell activation,M1,1,0
1,-10,GO:0098657,import into cell,M1,1,0
1,-4,GO:0032722,positive regulation of chemokine production,M1,1,0
1,-3.6,GO:0002705,positive regulation of leukocyte mediated immunity,M1,1,0
1,-13,GO:0001775,cell activation,M1,1,0
1,-3.3,GO:0006633,fatty acid biosynthetic process,M1,1,0
1,-9.7,GO:0071345,cellular response to cytokine stimulus,M1,1,0
1,-2.4,GO:0043425,bHLH transcription factor binding,M1,1,0
1,-5.5,GO:0051250,negative regulation of lymphocyte activation,M1,1,0
1,-5.2,GO:0030888,regulation of B cell proliferation,M1,1,0
1,-3.8,GO:0002685,regulation of leukocyte migration,M1,1,0
1,-2.5,GO:0043467,regulation of generation of precursor metabolites and energy,M1,1,0
1,-2.5,GO:0071549,cellular response to dexamethasone stimulus,M1,1,0
1,-3,GO:0001217,DNA-binding transcription repressor activity,M1,1,0
1,-4,GO:0072006,nephron development,M1,1,0
1,-3,GO:0071548,response to dexamethasone,M1,1,0
1,-3,GO:1903053,regulation of extracellular matrix organization,M1,1,0
1,-2,GO:0006351,DNA-templated transcription,M1,1,0
1,-3,GO:0045665,negative regulation of neuron differentiation,M1,1,0
1,-6.9,GO:0140962,multicellular organismal-level chemical homeostasis,M1,1,0
1,-2.6,GO:0045332,phospholipid translocation,M1,1,0
1,-5.9,GO:0002700,regulation of production of molecular mediator of immune response,M1,1,0
1,-2.5,GO:0001667,ameboidal-type cell migration,M1,1,0
1,-7.4,GO:0007167,enzyme-linked receptor protein signaling pathway,M1,1,0
1,-4.6,GO:0033500,carbohydrate homeostasis,M1,1,0
1,-3,GO:1990841,promoter-specific chromatin binding,M1,1,0
1,-3,GO:0043129,surfactant homeostasis,M1,1,0
1,-4,GO:0003014,renal system process,M1,1,0
1,-3.7,GO:0030217,T cell differentiation,M1,1,0
1,-2.8,GO:0072012,glomerulus vasculature development,M1,1,0
1,-2.7,GO:2000736,regulation of stem cell differentiation,M1,1,0
1,-3.7,GO:0045580,regulation of T cell differentiation,M1,1,0
1,-3,GO:0005520,insulin-like growth factor binding,M1,1,0
1,-2.6,GO:0071624,positive regulation of granulocyte chemotaxis,M1,1,0
1,-4.4,GO:0008525,phosphatidylcholine transporter activity,M1,1,0
1,-3.7,GO:0010721,negative regulation of cell development,M1,1,0
1,-2.8,GO:0097746,blood vessel diameter maintenance,M1,1,0
1,-4,GO:0003096,renal sodium ion transport,M1,1,0
1,-7.7,GO:0050870,positive regulation of T cell activation,M1,1,0
1,-13,GO:0048514,blood vessel morphogenesis,M1,1,0
1,-5.2,GO:0042277,peptide binding,M1,1,0
1,-3.2,GO:0140678,molecular function inhibitor activity,M1,1,0
1,-3.2,GO:0032496,response to lipopolysaccharide,M1,1,0
1,-4.2,GO:0009925,basal plasma membrane,M1,1,0
1,-2.6,GO:0051180,vitamin transport,M1,1,0
1,-5.4,GO:0060907,positive regulation of macrophage cytokine production,M1,1,0
1,-2.9,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,M1,1,0
1,-5.8,GO:0071363,cellular response to growth factor stimulus,M1,1,0
1,-5,GO:0038132,neuregulin binding,M1,1,0
1,-3.9,GO:0046635,positive regulation of alpha-beta T cell activation,M1,1,0
1,-5.6,GO:0045639,positive regulation of myeloid cell differentiation,M1,1,0
1,-4.9,GO:1905153,regulation of membrane invagination,M1,1,0
1,-5.1,GO:0009615,response to virus,M1,1,0
1,-4.5,GO:0031960,response to corticosteroid,M1,1,0
1,-3.9,GO:0050868,negative regulation of T cell activation,M1,1,0
1,-4.5,GO:0045178,basal part of cell,M1,1,0
1,-10,GO:0032103,positive regulation of response to external stimulus,M1,1,0
1,-3,GO:0030669,clathrin-coated endocytic vesicle membrane,M1,1,0
1,-5.3,GO:0045165,cell fate commitment,M1,1,0
